Yüklüyor......
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master regulator for cancer. Enormous efforts have been dedicated to the development of drugs targeting PI3K signaling, many of wh...
Kaydedildi:
| Yayımlandı: | Mol Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379961/ https://ncbi.nlm.nih.gov/pubmed/30782187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-0954-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|